Business Context and Reporting Period
Company: Matinas Biopharma Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date: September 9, 2015
Purpose: Disclosure of a corporate presentation intended for use at an investor conference.
Financial Metrics
This filing does not contain specific financial data. The document serves as a vehicle to disclose a presentation (Exhibit 99.1) rather than reporting revenue, profit, cash flow, margins, debt, or liquidity figures. The filing text does not provide a clear value for any financial metric.
Material Changes
No material changes to financial performance or operations are reported in this specific document. The filing is procedural, noting the intent to use a presentation for investor relations purposes.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to use the attached presentation (Exhibit 99.1) in connection with an investor conference.
Legal Status of Information: In accordance with General Instruction B.2 of Form 8-K, the information in this report and its exhibits is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934. It is not subject to the liabilities of that section and is not incorporated by reference into other filings unless expressly referenced.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (Corporate Presentation dated September 9, 2015) for actual business updates, as the 8-K text itself contains no operational details.
- Note that the presentation materials are not legally "filed" for liability purposes under the Exchange Act.
- Confirm the date of the investor conference where this presentation was utilized.